5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Africa Beta-Glucan Market is segmented By Category (Soluble and Insoluble); by Application (Food and Beverage, Healthcare and Dietary Supplements and Other Applications); by Source (Cereals, Yeast, Mushroom, and Other Sources); and by Geography.
Africa Beta-Glucan Market is projected to grow at a CAGR of 8.03% during the forecast period (2020-2025).
The Africa Beta-Glucan Market is segmented by category that includes soluble and insoluble. Based on the application, the market is divided into food and beverage, healthcare and dietary supplements, and other applications. The market is also classified according to the source including cereals, yeast, mushroom, and other sources. The study also involves the analysis of regions such as South Africa, Nigeria, Kenya, and the rest of Africa.
|Food and Beverage|
|Healthcare and Dietary Supplements|
Report scope can be customized per your requirements. Click here.
Manufacturers focus highly on extraction conditions, as the extraction conditions of beta-glucan are highly responsible for the ratio of the soluble and insoluble fraction. High solubility of soluble beta-glucan enables companies to produce products with a smooth texture. Soluble beta-glucan finds its applications increasingly in the cosmetics industry to manufacture creams and lotions, as it can be easily absorbed into the skin to achieve desired cosmetic or dermatologic results. Manufacturers are offering soluble beta-glucan that has higher water solubility compared to insoluble beta-glucan, thereby making it ideal for a wide array of applications. For instance, Tate & Lyle, offers PromOat Beta Glucan, a soluble oat bran fiber extracted from wholegrain oats and is free from chemicals. It is soluble and has strong water-binding and emulsifying properties, smooth and creamy texture in a variety of products, including beverages, dairy, soups, sauces, and dressings.
To understand key trends, Download Sample Report
In the healthcare industry, beta-glucans are used for improving immune response and are used as oral medicines or injections for treating a range of medical diseases and disorders including high cholesterol, Crohn’s disease, diabetes, cancer, and high blood pressure. Moreover, an increasing number of research studies have been carried out using beta-glucans to treat a range of chronic inflammatory skin diseases and other health conditions. Such research studies involve the usage of topical creams containing beta-glucan to study the effect of the medications for treating the disease. Thus, the increasing applications of beta-glucan in the healthcare industry have led to manufacturers offering beta-glucan to carry out research studies and introduce potent drugs.
To understand geography trends, Download Sample Report.
The Africa beta-glucan market is consolidated as the major players are competing for market share and with innovation in products being a major strategic approach adopted by leading players. Additionally, mergers, expansion, acquisitions, and partnerships with other companies are common strategies to enhance the company's presence and boost the market. The key players in the market are Tate & Lyle PLC, Koninklijke DSM N.V., Kerry Group, Lesaffre International, and Kemin Industries.
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
3.1 Market Overview
4. MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Porter's Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Bargaining Power of Buyers/Consumers
4.3.3 Bargaining Power of Suppliers
4.3.4 Threat of Substitute Products
4.3.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Source
5.2 By Category
5.3 By Application
5.3.1 Food and Beverage
5.3.2 Healthcare and Dietary Supplements
5.3.3 Other Applications
18.104.22.168 South Africa
22.214.171.124 Rest of Africa
6. COMPETITIVE LANDSCAPE
6.1 Most Active Companies
6.2 Most Adopted Strategies
6.3 Market Share Analysis
6.4 Company Profiles
6.4.1 Kerry Group
6.4.2 Koninklijke DSM N.V.
6.4.3 Tate & Lyle PLC
6.4.5 Merck KGaA
6.4.6 Kemin Industries
7. MARKET OPPORTUNITIES AND FUTURE TRENDS